GlucoTrack Inc (NASDAQ: GCTK) stock jumped 17.33% on Monday to $0.18 against a previous-day closing price of $0.15. With 5.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.17 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $0.1900 whereas the lowest price it dropped to was $0.1426. The 52-week range on GCTK shows that it touched its highest point at $3.75 and its lowest point at $0.13 during that stretch. Beta for the stock currently stands at -1.24.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GCTK was up-trending over the past week, with a rise of 10.83%, but this was down by -14.24% over a month. Three-month performance dropped to -36.81% while six-month performance fell -61.68%. The stock lost -91.00% in the past year, while it has lost -87.23% so far this year.
Float and Shares Shorts:
At present, 20.89 million GCTK shares are outstanding with a float of 15.54 million shares on hand for trading. On Oct 30, 2023, short shares totaled 24920.0, which was 0.12% higher than short shares on Sep 28, 2023. In addition to Mr. Paul V. Goode Ph.D. as the firm’s Chief Executive Officer, Mr. James P. Thrower Ph.D. serves as its CTO & VP of Engineering.
Institutional Ownership:
Through their ownership of 0.26% of GCTK’s outstanding shares, institutional investors have minority control over the company. As the largest shareholder in GCTK with 9.59% of the stake, Sabby Management LLC holds 2,004,230 shares worth 2,004,230. A second-largest stockholder of GCTK, Alerus Financial, NA, holds 69,279 shares, controlling over 0.33% of the firm’s shares. Boston Financial Management LLC is the third largest shareholder in GCTK, holding 52,744 shares or 0.25% stake.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GCTK since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
